US 12370194
Metalloenzyme inhibitor compounds
granted A61KA61K31/506
Quick answer
US patent 12370194 (Metalloenzyme inhibitor compounds) held by Eikonizo Therapeutics, Inc. expires Mon Jul 24 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Eikonizo Therapeutics, Inc.
- Grant date
- Tue Jul 29 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 24 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 21
- CPC classes
- A61K, A61K31/506